Optruma and basal cell carcinoma Patient Reports February 12, 2012



Optruma Side Effects Report #5197237-3
Optruma side effect was reported by a Physician from FRANCE on Dec 21, 2006. Female patient was diagnosed with osteopenia and was treated with Optruma. After drug was administered, patient experienced the following side effects: basal cell carcinoma. Optruma dosage: 60 MG, DAILY (1/D). Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Optruma